194 related articles for article (PubMed ID: 34716460)
1. Therapeutic efficacy of new botulinum toxin identified in CCUG 7968 strain.
An Y; Kim YJ; Kim CS; Yim H; Kim M; Lee EK; Oh HJ; Han JH; Yoo E; Kim S; Woo J; Moore ERB; Jung JY; Park W
Appl Microbiol Biotechnol; 2021 Dec; 105(23):8727-8737. PubMed ID: 34716460
[TBL] [Abstract][Full Text] [Related]
2. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution.
Tang-Liu DD; Aoki KR; Dolly JO; de Paiva A; Houchen TL; Chasseaud LF; Webber C
Toxicon; 2003 Oct; 42(5):461-9. PubMed ID: 14529727
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of a new botulinum toxin type A preparation in mouse gastrocnemius muscle.
Na J; Lee E; Kim YJ; Choi MJ; Kim SY; Nam JS; Yun BJ; Kim BJ
Toxicon; 2020 Nov; 187():163-170. PubMed ID: 32918927
[TBL] [Abstract][Full Text] [Related]
5. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
[TBL] [Abstract][Full Text] [Related]
6. Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain.
Zhang L; Lin WJ; Li S; Aoki KR
Gene; 2003 Oct; 315():21-32. PubMed ID: 14557061
[TBL] [Abstract][Full Text] [Related]
7. Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat.
Ma J; Shen J; Smith BP; Ritting A; Smith TL; Koman LA
J Bone Joint Surg Am; 2007 Oct; 89(10):2241-9. PubMed ID: 17908902
[TBL] [Abstract][Full Text] [Related]
8. Evidence for central antispastic effect of botulinum toxin type A.
Matak I
Br J Pharmacol; 2020 Jan; 177(1):65-76. PubMed ID: 31444910
[TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
Cai BB; Francis J; Brin MF; Broide RS
Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
[TBL] [Abstract][Full Text] [Related]
11. Comparative Pharmacodynamics of Three Different Botulinum Toxin Type A Preparations following Repeated Intramuscular Administration in Mice.
Byun J; Kwak S; Kwon JH; Shin M; Lee DK; Rhee CH; Kang WH; Oh JW; Cruz DJM
Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737026
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of treadmill therapy on neuromuscular atrophy induced via botulinum toxin A.
Tsai SW; Chen HL; Chang YC; Chen CM
Neural Plast; 2013; 2013():593271. PubMed ID: 24327926
[TBL] [Abstract][Full Text] [Related]
13. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.
Alexander C; Elliott C; Valentine J; Stannage K; Bear N; Donnelly CJ; Shipman P; Reid S
Dev Med Child Neurol; 2018 Nov; 60(11):1165-1171. PubMed ID: 30151852
[TBL] [Abstract][Full Text] [Related]
14. Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections.
Minamoto VB; Suzuki KP; Bremner SN; Lieber RL; Ward SR
Muscle Nerve; 2015 Oct; 52(4):649-57. PubMed ID: 25598004
[TBL] [Abstract][Full Text] [Related]
15. Differential response of pig masseter to botulinum neurotoxin serotypes a and b.
Liu ZJ; Rafferty KL; Ye W; Herring SW
Muscle Nerve; 2015 Jul; 52(1):88-93. PubMed ID: 26039454
[TBL] [Abstract][Full Text] [Related]
16. Dynamic muscle paralytic effects of a novel botulinum toxin A free of neurotoxin-associated proteins.
Liu WC; Su JH; Feng Y; Xiang XR; Pan LZ; Liu Y; Ma L; Nie ZY; Zhang XP; Jin LJ
Pharmacol Res Perspect; 2022 Jun; 10(3):e00955. PubMed ID: 35484714
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype.
Raphael BH; Lautenschlager M; Kalb SR; de Jong LI; Frace M; Lúquez C; Barr JR; Fernández RA; Maslanka SE
BMC Microbiol; 2012 Oct; 12():245. PubMed ID: 23113872
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of botulinum toxin: differences between type A preparations.
Rosales RL; Bigalke H; Dressler D
Eur J Neurol; 2006 Feb; 13 Suppl 1():2-10. PubMed ID: 16417591
[TBL] [Abstract][Full Text] [Related]
19. A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.
Lévêque C; Ferracci G; Maulet Y; Grand-Masson C; Blanchard MP; Seagar M; El Far O
Biosens Bioelectron; 2013 Nov; 49():276-81. PubMed ID: 23787358
[TBL] [Abstract][Full Text] [Related]
20. Treadmill running upregulates the expression of acetylcholine receptor in rat gastrocnemius following botulinum toxin A injection.
Tsai SW; Tung YT; Chen HL; Shen CJ; Chuang CH; Tang TY; Chen CM
J Orthop Res; 2013 Jan; 31(1):125-31. PubMed ID: 22733692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
